Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ABCG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF395 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BECN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V1B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXPE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505841 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYGD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
EPN2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM132E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OPN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on